![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 19, Issue 9, 3909-3922, September 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
at the Interface with Its Effectors PLCβ and PI3K
*Department of Pharmacology, Vanderbilt University, Nashville, TN 37232; and Department of Cell and Developmental Biology, University of Illinois, Urbana, IL 61801
Submitted April 28, 2008;
Revised June 18, 2008;
Accepted June 20, 2008
Monitoring Editor: Sandra L. Schmid
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
(Gβ) subunits, acts as a negative regulator of directed cell migration. After chemoattractant-induced polarization of Jurkat and neutrophil-like differentiated HL60 (dHL60) cells, RACK1 interacts with Gβ and is recruited to the leading edge. Down-regulation of RACK1 dramatically enhances chemotaxis of cells, whereas overexpression of RACK1 or a fragment of RACK1 that retains Gβ-binding capacity inhibits cell migration. Further studies reveal that RACK1 does not modulate cell migration through binding to other known interacting proteins such as PKCβ and Src. Rather, RACK1 selectively inhibits Gβ-stimulated phosphatidylinositol 3-kinase (PI3K) and phospholipase C (PLC) β activity, due to the competitive binding of RACK1, PI3K, and PLCβ to Gβ. Taken together, these findings provide a novel mechanism of regulating cell migration, i.e., RACK1-mediated interference with Gβ-dependent activation of key effectors critical for chemotaxis. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Charest and Firtel, 2006). Many chemoattractants, such as chemokines, act through G protein–coupled receptors (GPCRs) to promote directional cell migration (Rickert et al., 2000). These GPCRs typically activate the Gi/o family of G proteins, which in turn release Gβ. Free Gβ acts as a molecular switch to activate a myriad of signaling molecules, many of which are intimately involved in chemotaxis. For example, upon chemoattractant stimulation, free Gβ elicits rapid translocation of PI3K to the leading edge of cells, which in turn generates local accumulation of its lipid product phosphatidylinositol-3,4,5-trisphosphate (PIP3; Rickert et al., 2000). PIP3 recruits pleckstrin homology (PH) domain-containing proteins to the leading edge and activates small GTPases such as Rac and Cdc42, resulting in actin polymerization, cell polarization, and directional migration (Charest and Firtel, 2006). Free Gβ also stimulates PLCβ2/3, the most abundant isoforms of PLC in leukocytes, which regulate chemotaxis of T lymphocytes but not neutrophils (Li et al., 2000; Bach et al., 2007).
Chemotaxis is a complicated phenomenon involving multiple processes including gradient sensing, polarization, and motility (Charest and Firtel, 2006; Iglesias and Devreotes, 2008). In addition to excitatory signals, it has been proposed that the binding of chemoattractants to receptors also activate inhibitory pathways to antagonize the excitation response (Charest and Firtel, 2006; Iglesias and Devreotes, 2008). This inhibitory process is necessary for chemoattractants to generate a spatially localized excitatory signal and to allow cells to adapt to a constant stimulation. Over the past several years, several proteins that are involved in this inhibitory process have been identified. For example, in Dictyostelium, phosphatase PTEN is activated and redistributed to the lateral and trailing edges of cells, where it dephosphorylates PIP3 to PIP2, leading to a sharp gradient of PIP3 between the front and rear of cells (Funamoto et al., 2002; Iijima and Devreotes, 2002). In neutrophils, a RhoA-dependent signal at the trailing edge of cells counterregulates the excitatory signals generated by Gβ-dependent activation of PI3K and Rac at the leading edge of cells (Xu et al., 2003). However, to fully explain the chemotactic behaviors of cells, it has been proposed that there are other unknown inhibitory pathways (Xu et al., 2007; Iglesias and Devreotes, 2008).
Given its critical role in transmitting chemotactic signals, Gβ may serve as a central point for regulation of cell migration. However, despite a wide array of binding partners having been discovered for Gβ, little is known about how Gβ signaling is regulated to ensure precise control of directional cell movement (Hamm, 1998). Recently, we have identified RACK1 as a novel binding partner of Gβ (Chen et al., 2004b). RACK1 is a member of the WD40 repeat protein family that is predicted to adopt a β-propeller structure similar to that of Gβ. In addition to binding to activated protein kinase C (PKC), RACK1 has been shown to interact with a variety of proteins and may act as an adaptor/scaffold protein to orchestrate diverse cellular processes, ranging from signal transduction to cell growth (McCahill et al., 2002). However, our previous studies show that RACK1 binds to a unique region of Gβ and blocks the activation of selective Gβ effectors such as PLCβ (Chen et al., 2004a, 2005). Therefore, we reason that RACK1 may play a role in regulating Gβ-stimulated cell migration.
In this article, we provide evidence that RACK1 negatively regulates chemotaxis. Down-regulation of RACK1 promotes directional migration of Jurkat and dHL60 cells, whereas overexpression of RACK1 stops cell migration in its track. Moreover, we unveil that RACK1 dose not function through other known binding proteins such as PKCβ, Src, integrin, and extracellular signal-regulated kinases (ERKs) to modulate cell migration. Rather, it acts by selectively inhibiting Gβ-mediated PLCβ and PI3K activation, due to its binding to a unique effector–contact interface of Gβ. These findings provide a novel mechanism for RACK1 in regulating cell migration by acting on the Gβ/effector interface.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
). Transient transfection of HEK293A cells was achieved by using the Lipofectamine 2000 reagent (Invitrogen). Transfection of Jurkat T-cells (2–3 x 106) or dHL60 cells (1 x 107) 5 d after differentiation was performed by using Nucleofector Kit V and Necleofect II device (Amaxa Biosystems, Gaithersburg, MD) according to the manufacturer's protocol. Cells were harvested for assays 48–62 h after transfection. Jurkat cells stably expressing Flag-RACK1 or its deletion mutants Flag-BD1-2 and Flag-BD5-7 were generated after transfection and selection with increasing concentration of G418 (0.2–2 mg/ml) for 4–6 wk. Surviving cells were pooled and maintained in 1 mg/ml G418.
Small Interfering RNAs and DNA Constructs
Control small interfering RNA (siRNA) targeting green fluorescent protein (GFP) or luciferase and siRNA targeting human RACK1 (GNB2L1) gene sequence, 5' aagctgaagaccaaccaca, were purchased from Dharmacon Research (Boulder, CO).
The expression vectors for RACK1 and its deletion mutants BD1-2, BD3-4, and BD5-7, corresponding to different blades at residues 1–102, 103–189, and 190–317 of rat RACK1 were generated by PCR. They are first cloned into the entry vector, pENTR/SD/D-TOPO and then into the destination vectors pcDNA3-DEST and pMAL-DEST for expression in mammalian cell and Escherichia coli, respectively, by using the Gateway cloning system (Invitrogen). These destination vectors contain DNA sequences for epitope tags GST, Flag, or MBP at the N-terminus. pMAL-DEST was generated by inserting a sequence cassette encoding the ccdB gene flanked by attR sites into pMAL-c2E (New England Biolab, Beverly, MA).
Immunoprecipitation and Western Blotting Analysis
Before stimulation with SDF1
(20 nM), Jurkat cells were serum-starved for 4–6 h. Cell lysates were prepared with phosphate-buffered saline containing 1% Igepal, 0.2% deoxycholate, and protease inhibitors. Immunoprecipitation of Gβ or RACK1 was performed with 4 µg of rabbit anti-Gβ (T20) or mouse anti-RACK1 (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoprecipitates were resolved by SDS-PAGE and immunoblotted with mouse anti-RACK1 (BD Transduction Laboratories, Lexington, KY) or rabbit anti-PKC and anti-Src (Santa Cruz). To assay the interactions of Gβ with GST-tagged RACK1 or its mutants, HEK293 cells were transiently transfected with plasmid cDNAs encoding HA-Gβ1 and G2 as well as GST-RACK1 or its mutants. GST pulldown assays were then performed to determine the association of HA-Gβ with GST-RACK1 and its mutants (Chen et al., 2004a).
Phosphorylation of ERKs and AKT was determined by Western blotting using specific antibodies against phosphor-p44/42 MAPK (Thr202/Tyr204; E10) and phosphor-AKT (Ser473; 587F11; Cell Signaling Technology). Immunoblots were analyzed by Odyssey imaging system (Li-Cor Biosciences, Lincoln, NE).
Cell Polarization Assay
Polarization of Jurkat T-cells were performed by using Sulfate latex beads (Interfacial Dynamics, Portland, OR no. 1–5000) coated with 100 nM SDF1 and 20 µg/ml fibronectin (Takesono et al., 2004). Coated beads (2 x 106) were first plated onto poly-D-lysine–coated Lab-tek chamber slides and then mixed with prechilled Jurkat T-cells (2 x 106) to form complexes at 4°C. After the unbound cells were washed off, polarization reactions were started by incubation in 37°C water bath for 2 min and stopped by the addition of 4% paraformaldehyde. Polarization of dHL60 cells to a uniform concentration of f-Met-Leu-Phe (fMLP) were performed essentially as described (Wang et al., 2002). Fixed and permeabilized cells were stained with mouse anti-RACK1 (1:400 dilution) and rabbit anti-Gβ (T20; 1:400 dilution) at 4°C overnight and then incubated with secondary antibodies Alexa 488–conjugated anti-rabbit and Cy5-conjugated anti-mouse and rhodamine-conjugated phalloidin (1:400 dilution) for 1 h at RT. Slides were visualized with a LSM510 Meta inverted confocal microscope (Carl Zeiss, Jena, Germany) with an argon/krypton laser and a Plan Apo 40x 1.3 NA oil immersion lens (Chen et al., 2004a). Images were acquired and processed with LSM5 Image software (Carl Zeiss) and Adobe Photoshop (San Jose, CA).
Chemotaxis Assays
Chemotaxis assays were performed in 96-well modified Boyden chamber (Neuro Probe, Cabin John, MD) as described with modifications (Chen et al., 2004a). Briefly, for the measurement of Jurkat cell migration, cells were first labeled with 5 µM Calcein-AM for 30 min at 37°C and washed with serum-free RPMI containing 0.1% BSA twice. Cell migration was determined by using 5 µm pore-size uncoated polycarbonate membrane filters and incubation for 3 h at 37°C in 5% CO2. Cells, 4–5 x 106, were loaded to the upper chamber. The migration of cells from the upper chamber to the lower chamber containing chemoattractants was quantified by measuring Calcein fluorescence in a fluorescent plate reader (Victor II, PerkinElmer, Waltham, MA), and converting to the number of cells based on a standard curve. The percentage of migration was calculated by the number of cells in the lower chamber divided by the sum of cells put in the upper chamber at the beginning of experiments.
To measure chemotaxis of siRNA-treated dHL60 cells, cells were cotransfected with GFP and 8 µm pore-size fibronectin-coated polycarbonate membrane filters were used in the assay. The percentage of GFP-positive cells migrating from the upper chamber to the lower chamber was calculated by counting the cells under fluorescence microscope.
Measurement of Inositol Phosphate Accumulation
Jurkat cells (2 x 106) were labeled with [3H]inositol (5 µCi/ml) in inositol-free DMEM containing 1% dialyzed FCS for 2 d. Inositol phosphate (IP) accumulation was determined as described (Chen et al., 2004a).
Rho Activation Assay
RhoGTP levels in Jurkat cells were assessed by using a Rhotekin Rho-binding domain (RBD) affinity precipitation assay (Ren and Schwartz, 2000). Briefly, after serum-starvation overnight, 1 x 107cells were stimulated with SDF1 (100 nM) for the indicated times. The reaction was stopped by adding 5x lysis buffer at 4°C (1x lysis buffer: 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% Igepal, 10 mM MgCl2, 1 mM EDTA, and 10% glycerol). Cell lysates were prepared and the level of RhoGTP in the lysates was determined by using Rhotekine-RBD bound to glutathione-Sepharose beads as described previously (Ren and Schwartz, 2000).
Purification of Gβ12, PI3K, and Other Proteins
PI3K was expressed in Sf9 cells by infection with baculoviruses encoding 6xHis-p110 and EE-p101 (kindly provided by Dr. Len Stephens, The Babraham Institute, Cambridge, United Kingdom) and sequentially purified to near homogeneity using Ni-NTG and anti-EE-Sepharose (Stephens et al., 1994). Gβ12, MBP, MBP-RACK1, MBP-BD1-2, and MBP-BD5-7 were purified as described (Chen et al., 2004a, 2005). The C-terminal tail (the last 124 aa) of the rat homolog G protein–coupled receptor kinase 2 (GRK2-ct) was expressed as a His-tagged protein in E. coli and purified as described (Blackmer et al., 2001).
Measurement of PI3K Activity
Gβ-mediated PI3K activation was determined essentially as described before (Kerchner et al., 2004). To determine the effect of RACK1 and its mutants, they were preincubated with Gβ12 (100 nM) for 30 min before the addition of PI3K (50 ng) and lipid vesicles.
Measurement of PKC
Activity
Jurkat cells (1 x 107) were stimulated with SDF1 (50 nM) for 5 min and then lysed in the buffer (25 mM Tris, pH 7.5, 1% Triton, 0.5 mM EDTA, 150 mM NaCl, 50 mM NF, NaVO3, PMSF, and protease inhibitor cocktail). PKC was immunoprecipitated from the cell lysates with rabbit anti-PKC antibody (Santa Cruz Biotechnology). The activity of PKC was determined by using the PKC assay kit (Upstate Biotechnology, Lake Placid, NY) and PKC substrate peptide 2 (Upstate) as a substrate.
Mathematical Modeling
To describe RACK1 and GRK2-ct dependent inhibition of Gβ-mediated PI3K activation, we assumed that the regression curve follows the rule of competitive inhibition. Theoretical simulation of the reactions was performed by using MatLab (The Math Works, Natick, MA) on a Linux-based operating system (Ogdensburg, NY; McLaughlin et al., 2005).
Time-Lapse Experiments
dHL60 cells were stimulated with a point source of fMLP and imaged at RT using an inverted microscope (Zeiss Axiovert 200M) equipped with a cooled CCD camera (AxioCam MR3, Zeiss) driven by AxioVision Rel. 4.5 software (Wang et al., 2002). Images were taken with a Zeiss 40x, NA 1.30 Fluor DIC objective. Cell trajectories were tracked using Metamorph software (Molecular Devices, Sunnyvale, CA). The migration speed and chemotactic index were calculated as described previously (Wang et al., 2002).
Data Analysis
Unless indicated, data were representative of at least three independent experiments with similar results. Results are expressed as the mean ± 1 SEM from multiple experiments. Student's t tests were used to determine significant differences (two-tailed p < 0.05).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
stimulated chemotaxis of Jurkat cells in a dose-dependent manner (Figure 1A; Curnock et al., 2003). Transfection of Jurkat cells with a siRNA against human RACK1 inhibited its expression by more than 80% (Figure 1B). The effect of the RACK1 siRNA is specific, as it did not affect the level of other proteins including Gβ and CXCR4 (Figure 1A, inset). Notably, down-regulation of RACK1 significantly enhanced SDF1-stimulated cell migration (Figure 1A), but had no effect on general motility of cells, as the transwell migration of cells in the absence of SDF1 gradient is unaffected by decreased RACK1 expression (Figure 1A). These findings indicate that RACK1 negatively regulates chemotaxis but not random migration of Jurkat cells. Supporting this, a modestly increased expression of RACK1 (
30%) in Jurkat cells diminished cell migration response to SDF1 stimulation (Figure 1B).
|
is known to play a central role in chemotactic response of leukocytes to chemoattractants (Rickert et al., 2000). We have shown previously that RACK1 can bind Gβ and selectively regulate its functions (Chen et al., 2004a), suggesting that RACK1 may impinge on cell migration by interaction with Gβ. However, RACK1 is a multifunctional protein that has been shown to interact with many other proteins that are known to be involved in cell migration, such as integrin, PKC, Src, and ERKs (Schechtman and Mochly-Rosen, 2001; Chang et al., 2002; Vomastek et al., 2007). We therefore first evaluated if these RACK1-interacting proteins play a role in Jurkat cell migration. In the transwell assay, Jurkat cell migration through the filter membrane does not rely on cell adhesion to extracellular substrates via integrins because chemotaxis does not depend on whether the filter is coated with or without fibronectin or collagen (data not shown). This suggests that RACK1 is unlikely to modulate Jurkat cell migration via its interaction with integrin. Indeed, inhibition of RACK1 enhanced Jurkat cell migration equally well through the filter coated with or without fibronectin (data not shown). Studies with pharmacological inhibitors of Src kinases, PP2, a broad inhibitor of the Src family of protein tyrosine kinases, and Src inhibitor I, a selective inhibitor of Src and Lck, and an inhibitor of ERKs, PD98059, indicate that none of these proteins plays a major role in Jurkat cell migration because abrogation of their activity had little effect on chemotaxis of Jurkat cells treated with or without RACK1-siRNA (Figure 2, A–C). Similarly, inhibition of PKC with Go6976, which is known to selectively block the activity of the DAG-dependent PKCs, including the conventional and novel PKCs such as PKCβ and PKC
that are known to interact with RACK1 (Schechtman and Mochly-Rosen, 2001), did not affect chemotaxis (Figure 2A).
|
, we first evaluated the association of endogenous RACK1 with Gβ in Jurkat cells by immunoprecipitation of Gβ with an antibody that recognizes Gβ1, 2, 3, and 4 isoforms. As shown in Figure 3A, a significant amount of RACK1 was associated with Gβ in untreated cells, and this association was significantly enhanced after SDF1 treatment for 30 min. Under the same conditions, immunoprecipitation of RACK1 did not precipitate PKCβ, Src, or the related kinase Lck (data not shown), suggesting a possibility of specific association of RACK1 with Gβ in Jurkat cells.
|
. To induce Jurkat cell polarization, we treated cells with SDF1-coated beads, because Jurkat cells do not polarize well in response to a uniform concentration of chemoattractants. As shown in Figure 3B, cells immobilized on control beads displayed a rounded morphology with little F-actin staining. A majority of Gβ in these cells was uniformly distributed in the plasma membrane, with a small fraction detected in the cytoplasm and nucleus. RACK1, on the other hand, was detected mostly in the cytoplasm, where it partially colocalizes with Gβ. Stimulation of cells with SDF1-coated beads induced cell polarization, increased F-actin accumulation and substantial relocation of Gβ at the membrane protrusion that contacts the bead (Figure 3B). Translocation of RACK1 to the polarized front end of cells was also evident in these cells and colocalization of RACK1 with Gβ was detected primarily in the membrane protrusion. Pretreatment of cells with pertussis toxin (PTx), which uncouples Gi/o classes of G proteins from their cognate receptors, inhibited cell polarization, actin accumulation and translocation of both Gβ and RACK1 (data not shown). These findings are consistent with the previous report that free Gβ released from activated Gi/o is primarily responsible for SDF1-stimulated actin polymerization and cell polarization (Takesono et al., 2004).
To dissect the molecular basis of RACK1/Gβ interaction, we determined the domains of RACK1 required for binding Gβ. We constructed a series of RACK1 deletion mutants and expressed them as GST-conjugated proteins together with Gβ in HEK293 cells (Figure 3C). GST pulldown assays showed that the N-terminal fragment of RACK1 consisting of the first two blades retained substantial binding to Gβ, whereas the C-terminal fragments (BD3–4 and BD5–7) showed little binding to Gβ, suggesting that the N-terminal domain of RACK1 is the major determinant for the interaction (Figure 3C). The Gβ-binding sites on RACK1 are likely located on the β-propeller blades themselves and not on the short N-terminal extension, because single-blade mutants BD1 and BD2 can still interact with Gβ (data not shown). We have shown previously that the RACK1 contact surface is also located on the β-propeller blades of Gβ (Chen et al., 2005). Because these blades are defined by the WD40 repeats, these results indicate that the RACK1/Gβ interaction is mediated by their WD40 motifs, a possibly novel mode of protein–protein interactions. In contrast to binding to Gβ, none of RACK1 mutants, BD1–2, BD3–4, and BD5–7, retains the ability to interact with two other known RACK1-binding proteins, PKCβ and Src, as the full-length RACK1, suggesting that unlike Gβ, the binding of these proteins to RACK1 requires the coordinated interactions with its multiple domains (Figure 3D).
To test whether RACK1 inhibits cell migration via its interaction with Gβ, we stably expressed Flag-BD1–2 and Flag-BD5–7 in Jurkat cells at levels comparable to the full-length RACK1. Interestingly, only cells expressing BD1–2 exhibited a diminished ability to migrate to SDF1 gradient, whereas cells expressing BD5–7 did not (Figure 1B). Because BD1–2 but not BD5–7 retains Gβ-binding capacity, these data suggest that RACK1 regulates cell migration through its physical association with Gβ.
RACK1 Regulates Cell Migration by Inhibiting PLC and PI3K Signaling Pathways
Gβ regulates a variety of effectors including PLCβ, PI3Ks, and ERKs (Hamm, 1998). To test whether RACK1 regulates these pathways, we first assessed the effect of inhibiting RACK1 expression on the activity of PLCβ, PI3Ks, and ERKs. The activity of PLCβ in Jurkat cells was assessed by IP production. As shown in Figure 4A, in cells treated with a control siRNA, SDF1 stimulated little increase in IPs. However, this response was significantly enhanced by treatment of cells with a siRNA against RACK1. The increased IPs can be blocked by pretreatment of cells with either PTx or the PLC-specific inhibitor, U73122
[GenBank]
, but not by its inactive analog U73343
[GenBank]
, or the PI3K inhibitor, LY294002 (Figure 4B). Because inhibition of RACK1 did not alter the expression of CXCR4, Gβ and PLCβ (data not shown), these findings suggest that the enhanced IP signaling is due to increased PLC activity.
|
-induced AKT phosphorylation, which was completely abolished by PTx or LY294002 (data not shown), suggesting that the activation of AKT is downstream of Gβ and PI3K. The effect of silencing RACK1 on augmenting AKT phosphorylation is specific to GPCR-mediated signal transduction, because RACK1 depletion impaired the ability of T-cell receptor to stimulate further increase in AKT phosphorylation above the enhanced basal level (Figure 5C). Supporting the inhibitory role of RACK1 in regulating PI3K activation, overexpression of RACK1 inhibited both basal and SDF1-stimulated AKT phosphorylation (Figure 5B). Notably, the mutant BD1–2 but not BD5–7 mimicked the inhibitory effect of the full-length RACK1 (Figure 5B and data not shown), suggesting that RACK1 likely regulates PI3K activity by binding Gβ.
|
simulates PKC to regulate human CD34+ progenitor cell migration (Petit et al., 2005). To determine if RACK1 also regulates PKC via PI3K in Jurkat cells, we evaluated the effect of RACK1 depletion on PKC activity. As shown in Figure 5D, SDF1 activates PKC, and both the basal and SDF1-stimulated PKC activities are enhanced by inhibition of RACK1. Moreover, the activity of PKC is sensitive to both a pan-inhibitor of PKC, chelerythrine, and PI3K inhibitor, LY 294002, suggesting that PKC may be regulated downstream of Gβ-activated PI3K.
In contrast to its effects on PLC, PI3K, and PKC activities, silencing RACK1 did not affect either basal or SDF1-stimulated ERK activity, although the activation of ERK was completely abolished by PTx, suggesting the involvement of Gβ (Figure 6A and data not shown). Likewise, silencing RACK1 did not affect SDF1-induced RhoA activity, which is activated via G13 subunits in Jurkat cells (Figure 6B; Tan et al., 2006). Together, these findings suggest that RACK1 selectively inhibits Gβ-mediated PLCβ and PI3K activation.
|
-induced chemotaxis of Jurkat cells (Curnock et al., 2003; N'Diaye and Brown, 2003). To verify that RACK1 regulates chemotaxis via these pathways, we treated cells transfected with control or RACK siRNA with specific inhibitors. As shown in Figure 7A, PTx and U73122
[GenBank]
(but not U73343
[GenBank]
) prevented chemotaxis of both cells. The PI3K-specific inhibitors, wortmannin and LY294002, also largely abrogated cell migration (Figure 7B). Similar results were obtained with a specific PI3K inhibitor, PI3K inhibitor II (Camps et al., 2005), suggesting the involvement of PI3K (data not shown). As expected, RACK1 siRNA-treated cells exhibited lower sensitivity to wortmannin, probably due to the enhanced PI3K activity as a result of RACK1 down-regulation (Figure 7B). Consistent with the role of PKC in cell migration, inhibition of its activity by chelerythrine or the palmitoylated peptide corresponding to the pseudosubstrate region of PKC also completely abrogated cell migration (Figure 7C). These findings indicate that RACK1-mediated inhibition of the activity of Gβ-induced PLC, PI3K and its downstream effector, PKC, contributes to its abrogation of Jurkat cell migration.
|
-induced PI3K Activation by Steric Hindrance-mediated PLCβ activation by competitive binding to the region of Gβ critical for PLCβ interaction and activation (Chen et al., 2005). In Jurkat cells, PI3K is the primary PI3K responsible for SDF1-stimulated PIP3 production and chemotaxis and is known to be directly activated by interaction with Gβ (Curnock et al., 2003). To determine if RACK1 interferes with PI3K activation via binding to Gβ, we assessed the effect of RACK1 on Gβ-stimulated PI3K activity in vitro. As shown in Figure 8A, RACK1 itself did not stimulate PI3K activity but inhibited Gβ12-induced PI3K activation in a dose-dependent manner as GRK2-ct, a Gβ scavenger. However, compared with GRK-ct, RACK1 inhibition of PI3K was partial. At the concentration of 20 µM, RACK1 reduced PI3K activity by 50%, whereas at the same concentration, GRK2-ct completely abolished PI3K activation (Figure 8A).
|
reflects the relatively lower binding affinity of Gβ to RACK1 (EC50 520 nM) than PI3K (EC50 5.6 nM) and GRK2-ct (EC50 100 nM; Pumiglia et al., 1995; Kerchner et al., 2004; Chen et al., 2005), we have generated a mathematical model to describe the effect of RACK1 and GRK2-ct on PI3K activation (Supplementary Figure S1, A–C). We assumed that both RACK1 and GRK2-ct competitively inhibit Gβ-dependent PI3K activity. Initial simulations predicted regression curves for both GRK2ct- and RACK1-mediated inhibition of PI3K qualitatively matching those observed experimentally but slightly left-shifted (Supplementary Figure S2A), suggesting that the empirically determined potencies of RACK1 and GRK2-ct in inhibiting PI3K may be slightly lower than the theoretical predictions. However, an almost perfect fit between the simulations and empirical data for both GRK2-ct and RACK1 can be achieved when either the affinities of Gβ12 for RACK1 and GRK2-ct are set to be twofold lower (200 and 1040 nM, respectively), or the affinity of Gβ12 for PI3K is set to be twofold higher (2.8 nM; Supplementary Figure S2, B and C). Because these values are well within the range of variations reported for each parameter in the literature (Pumiglia et al., 1995; Maier et al., 1999; Maier et al., 2000; Kerchner et al., 2004; Chen et al., 2005), this indicates that the experimental data we obtained for both GRK2-ct and RACK1 are comparable to the theoretical predictions. Taken together, these results indicate that like GRK2-ct, RACK1 regulates PI3K activity by competitive binding to Gβ. Interestingly, the inhibitory effect of RACK1 on PI3K can be mimicked by the mutant BD1–2 but not BD5–7 or MBP alone, further underscoring the notion that RACK1 regulates PI3K activity through its direct interaction with Gβ (Figure 8A).
RACK1 was shown previously to bind to a noncanonical region of Gβ involved in activation of select effectors (Chen et al., 2005). To determine if this region is also involved in PI3K stimulation, we further deciphered the domains on Gβ that are critical for PI3K activation. We evaluated effects of a series of peptides derived from the β-propeller regions of Gβ1 on the activity of PI3K (Chen et al., 2005). To ensure maximal effects, we used a saturating concentration (0.5 mM) of the peptides. As shown in Figure 8B, of 15 peptides tested, only peptides 86–105, 113–122, 113–135, 136–147, 159–167, 201–209, and 309–316 inhibited 15–40% of Gβ-stimulated PI3K activity. These findings suggest that activation of PI3K involves multiple domains of Gβ, which contribute differentially to PI3K activation. When mapped to the crystal structure of Gβ11, the corresponding residues of the six inhibitory peptides occupy an extended surface of Gβ1. Two inhibitory peptides, p86–105 and 309–316, fall within the RACK1 contact surface, whereas five inhibitory peptides, p86–105, p113–122, p136–147, p201–209, p309–316, and p328–337, overlap with the GRK2 binding sites in Gβ (as determined from the cocrystal structure of the GRK2/Gβ12 complex (Lodowski et al., 2003); Figure 8, C and D). The fact that RACK1 and GRK2 binding sites on Gβ overlap with the PI3K contact surface indicates that RACK1 and GRK2 inhibit PI3K by preventing its access to the region of Gβ critical for its activation.
RACK1 Regulates Chemotaxis of Neutrophil-like dHL60 Cells
Having established that RACK1 inhibits chemotaxis of Jurkat cells, a transformed T-cell line, we sought to explore whether RACK1 also plays a role in migratory response of dHL60 cells, a human neutrophil-like cell line. Like Jurkat cells, dHL60 cells also express RACK1 but its level is significantly lower than that in Jurkat cells, although the level of total Gβ is comparable between these two cell lines (Figure 9A). As seen in Jurkat cells, RACK1 was located mostly in the cytoplasm, whereas Gβ was detected mainly in the plasma membrane of unstimulated cells (Figure 9B). However, in cells that polarized in response to a uniformly increased concentration of chemoattractant, fMLP, both Gβ and RACK1 were distributed in an anterior-to-posterior gradient. As in Jurkat cells, Gβ and RACK1 were mainly colocalized to the leading edge of cells (Figure 9B). Interestingly, a substantial amount of Gβ also accumulated in the cytoplasm, a phenomenon that has been noticed previously in other cell types (Kino et al., 2005; Saini et al., 2007). Moreover, the anterior-to-posterior gradient of Gβ was shallower than that of RACK1. This shallow distribution of Gβ is consistent with that was reported in polarized Dictyostelium discoideum amoebas (Jin et al., 2000). We showed previously that free Gβ can promote the translocation of RACK1 from the cytoplasm to the plasma membrane (Chen et al., 2004a). The fact that the gradient of RACK1 in polarized dHL60 cells exceeds that of Gβ suggests that in addition to Gβ-induced translocation, other mechanisms must amplify and maintain the gradient of RACK1 in these cells.
|
To further understand the role of RACK1 in the dynamic process of cell migration, we cotransfected dHL60 cells with RACK1 or RACK1 siRNA and PH-AKT-GFP, a bioprobe for PIP3, by using an optimized procedure that yields more than 80% cotransfection efficiency (Srinivasan et al., 2003). In addition to being a transfection marker, PH-AKT-GFP also serves as a probe for examining the effect of altering RACK1 expression on the spatiotemporal kinetics of PI3K activation. As reported, PH-AKT-GFP was distributed mostly in the cytoplasm of unstimulated dHL60 cells (Figure 10A; Servant et al., 2000). In responding to a gradient of fMLP delivered by a micropipette, control dHL60 cells rapidly developed a pseudopod at the part of cells that received the strongest stimulation. Moreover, fMLP stimulated translocation of PH-AKT-GFP from the cytoplasm to the pseudopod at the leading edge, resulting in a steep anterior to posterior gradient, which was stable over the entire course of cell migration (Figure 10A and Supplementary Video 1). These cells migrated linearly toward the source of stimuli with a speed of 5 µm/min and a chemotaxis index of 0.8, which reflects an almost straight line migration of cells from the starting point to the fMLP-containing micropipette (Figure 10A). Cotransfection of dHL60 cells with a siRNA against RACK1 did not cause significant changes either in their migration speed, directionality or the spatial and temporal kinetics of PH-AKT-GFP translocation, when exposed to a point source of fMLP (Figure 10, B and F, and Supplementary Video 2). The failure to modulate dHL60 cell migration by RACK1 depletion may be due to the fact that the micropipette system delivers a much steeper chemoattractant gradient than the modified Boyden chamber used in the transwell assays (Servant et al., 2000), such that the change in dHL60 cell migration due to the down-regulation of RACK1 could not be detected.
|
-mediated PI3K activation (Figure 8A). However, we did observe that some cells expressing RACK1 completely lost the ability to migrate toward the chemoattractant (Supplementary Video 3-2). This may reflect higher levels of RACK1 expression in these cells, resulting in a more severe inhibition of PI3K activation and PIP3 generation, thereby disrupting the positive feedback exerted by PIP3 on PI3K activation, which has been shown to be required for the formation of persistent pseudopod and directed cell migration (Wang et al., 2002; Weiner et al., 2002).
Interestingly, cells expressing BD1–2 showed chemotactic defects similar to those of RACK1-overexpressing cells, whereas cells expressing BD5–7 retained the wild-type-like chemotactic responses (Figure 10, D–F, and Supplementary Videos 4 and 5). These findings suggest that as in Jurkat cells, RACK1 regulates chemotaxis of dHL60 cells by its interaction with Gβ, thereby competing with PI3K binding and inhibiting its activation.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
and effector interface. Our data indicate that RACK1 acts as a negative regulator of chemotaxis. Thus, silencing RACK1 enhances SDF1- and fMLP-stimulated chemotaxis of Jurkat and dHL60 cells, whereas overexpressing RACK1 abrogates cell migration. The fact that RACK1 inhibits chemotaxis of both Jurkat and dHL60 cells induced via two different GPCRs suggests that RACK1 may have a general role in regulating GPCR-mediated leukocyte migration.
Several lines of evidence indicate that RACK1 regulates GPCR-directed cell migration by acting on Gβ to intervene selectively in the activation of its effectors PLC and PI3K. First, the activity of PLC and PI3K can be significantly augmented by down-regulation of RACK1, whereas overexpression of RACK1 has an opposite effect. Second, inhibiting RACK1 neither affects G13-mediated RhoA activation, nor has an effect on Gβ-mediated ERK activation, indicating that RACK1 selectively regulates Gβ effectors. Third, the inhibitory effect of RACK1 on effector activation and chemotaxis can only be mimicked by its mutant BD1-2, which retains Gβ-binding capacity but does not bind other RACK1-interacting proteins such as Src and PKCβ that are known to be involved in cell migration, suggesting that RACK1 exerts its function by physical association with Gβ. Supporting this, endogenous RACK1 was found to form a complex with Gβ, and these proteins are colocalized at the leading edge of both polarized Jurkat and dHL60 cells. Finally, our in vitro data provided direct evidence that RACK1 inhibits Gβ-stimulated PLCβ and PI3K activity by binding to Gβ. We showed previously that RACK1 inhibits PLCβ activation by competing for its binding to the signal transfer region of Gβ (Chen et al., 2005). In the present studies, we demonstrate that RACK1 uses a similar mechanism to regulate Gβ-stimulate PI3K activation. Thus, as with PLCβ2, RACK1 and its mutant BD1–2 inhibit PI3K in a dose-dependent manner. Compared with GRK2ct, RACK1 displays a lower potency in inhibiting PI3K (IC50 20 µM vs. 4 µM for GRK2). Mathematical simulation indicates that the lower potency of RACK1 in inhibiting PI3K reflects the relatively lower binding affinity of Gβ to RACK1 (EC50 500 nM) than GRK2ct (EC50 100 nM; data not shown; Pumiglia et al., 1995; Chen et al., 2005). It is worth noting that we do not know the exact binding affinity of RACK1 to Gβ in intact cells because RACK1 may undergo posttranslational modification, which could significantly alter its binding ability. However, the relatively lower potency of RACK1 in inhibiting Gβ signaling may facilitate its ability to regulate Gβ effectors in a spatiotemporal-specific manner because the inhibitory effect of RACK1 will critically depend on its relative local concentration in cells to the effectors.
Using a peptide-based approach, we also identified residues on Gβ that are critical for PI3K activation. Although in this assay the concentration of these peptides required to inhibit PI3K is relatively high and the effect of inhibition (15–40%) is modest, we believe that this reflects the relative contribution of the corresponding residues of the peptides to Gβ-mediated PI3K activation rather than nonspecific effects. First, the inhibitory effect of the peptides is effector-specific. For example, in our previous studies (Chen et al., 2005), the peptide p44–54 inhibits the binding of Gβ to PLCβ2 by 60% and directly activates PLCβ2, but it does not affect either the basal or Gβ-stimulated PI3K activity in the current studies. Similarly, although the peptide p177–189 caused more than 70% inhibition of Gβ-dependent PLCβ2 activity (Chen et al., 2005), it does not affect PI3K activation. Conversely, the peptide 309–316, which inhibited PI3K activation by 20%, had no effects on PLCβ2 activation (Chen et al., 2005). Second, some of the Gβ effector-binding sites identified by the peptide-based approaches have been corroborated by site-directed mutagenesis studies. For example, by substituting the charged amino acid within residues 44–54 of Gβ with alanines, we confirmed the results from the peptide-based studies that these residues play a critical role in PLCβ2 activation (Chen et al., 2005). Although we have not yet evaluated the contribution of different amino acids of Gβ to PI3K activation, previous studies from Garrison's group demonstrated that mutation of residues H311, R314, and V315 impaired the ability of Gβ to activate PI3K (Kerchner et al., 2004). These residues are contained in the peptide 309–316, which inhibited 20% of Gβ-dependent PI3K activity in our studies. Though our data remain to be corroborated by a high-resolution crystal structure of the Gβ/PI3K complex, our findings that some of Gβ residues (residues 86–105 and 309–316) critical for PI3K activation are contained in the RACK1 contact surface on Gβ is consistent with the notion that RACK1 regulates cell migration by physical association with and steric hindrance of the access of specific effectors to Gβ.
Our findings that RACK1 regulates chemotaxis via PLCβ and PI3K are consistent with the roles of these two enzymes in leukocyte migration, as demonstrated by numerous studies from gene knockout mice of PLCβ2/3 and PI3K and with pharmacological inhibitors (Rickert et al., 2000; Hawkins et al., 2006). However, the relative contribution of these two pathways in RACK1-mediated regulation of chemotaxis remains to be elucidated.
Like Gβ, RACK1 has numerous interacting proteins and is generally considered as a scaffold/adaptor protein involved in diverse of cellular processes. It has also been shown to be involved in migration of epithelia cells, partially through its interaction with PKCβ or PKC, Src, and integrins (Buensuceso et al., 2001; McCahill et al., 2002; Buensuceso et al., 2005; Kiely et al., 2005; Doan and Huttenlocher, 2007). However, conflicting reports of RACK1 in either promoting or inhibiting cell migration are found in literature, probably reflecting the context-dependent functions of RACK1 in cells, tissues, and stimuli (Buensuceso et al., 2001; Doan and Huttenlocher, 2007). In our studies, we did not detect interaction of RACK1 with either PKCβ or Src in Jurkat cells. Moreover, in the transwell assay, Jurkat cell migration through the filter membrane does not rely on cell adhesion to extracellular substrates via integrins. These data suggest that RACK1 is unlikely to modulate leukocyte migration through its effect on the activity of PKCβ, Src, or integrins. Supporting this, the RACK1 mutant BD1–2, which does not bind PKCβ and Src, can still mimic the inhibitory effect of the full-length RACK1. Moreover, studies with pharmacological inhibitors of Src, PKCβ/, and ERKs indicate that they are not involved in SDF1-stimulated Jurkat cell migration.
Our data unambiguously demonstrate that RACK1 plays a negative role in regulating leukocyte migration. Moreover, they provide further support for our previous notion that RACK1 can tune Gβ activation of effectors to impact specific functions of Gβ (Chen et al., 2004a). This mechanism of modulating cell migration is different from that used by other known regulators. For example, the phosphatases PTEN and SHIP impinge on directional sensing and motility of cells by dephosphorylating PIP3 (Franca-Koh et al., 2007; Nishio et al., 2007). Moreover, they are essential for the establishment of internal gradient of signaling molecules and directional sensing of Dictyostelium and neutrophils (Funamoto et al., 2002; Iijima and Devreotes, 2002; Li et al., 2005; Nishio et al., 2007). In contrast, RACK1 is not essential for gradient sensing as inhibition of RACK1 neither affects the translocation of PH-AKT-GFP to the leading edge nor the directional migration of dHL60 cells. Unlike RACK1, other regulatory proteins such as arrestins and GRKs negatively modulate chemotactic responses of leukocytes by down-regulating functions of chemokine receptors through phosphorylation and internalization of GPCRs (Vroon et al., 2006). Regulator of G protein signaling (RGS) proteins inhibit chemotaxis by shortening the lifetime of the active G-GTP subunit (Kehrl, 2006). Given the fact that RACK1 modulates cell migration via competitive inhibition of Gβ effector activation, it is conceivable that dynamic changes in the expression level of RACK1 during physiological and pathological processes of immune responses may contribute to fine tuning of leukocyte function. Additionally, because RACK1 is ubiquitously expressed, and chemokine receptors are involved in the migration of diverse cell types, including fibroblasts and endothelial and tumor cells, RACK1 may also function in other cellular processes, such as wound healing, angiogenesis, and tumor metastasis (Gillitzer and Goebeler, 2001; Balkwill, 2004; Strieter et al., 2005).
|
ACKNOWLEDGMENTS |
|---|
p < 0.05, significant difference versus SiCT. Wort, wortmannin; LY, LY294002; mpPKC
